Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 128 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Measures of disease status in systemic sclerosis: a systematic reviewTay, T.; Ferdowsi, N.; Baron, M.; Stevens, W.; Hudson, M.; Proudman, S.; Nikpour, M.; Damage Index Working Group of the Scleroderma Clinical Trials Consortium
2016Effect of adherence to protocolized targeted intensifications of disease-modifying antirheumatic drugs on treatment outcomes in rheumatoid arthritis: results from an Australian early arthritis cohortWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2012N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control studyThakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Liew, D.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.
2017Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathwaysWalsh, A.; Wechalekar, M.; Guo, Y.; Yin, X.; Weedon, H.; Proudman, S.; Smith, M.; Nagpal, S.
2017A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adultsMorrisroe, K.; Stevens, W.; Proudman, S.; Nikpour, M.
2012Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritisWiese, M.; Schnabl, M.; O'Doherty, C.; Spargo, L.; Sorich, M.; Cleland, L.; Proudman, S.
2010Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physiciansMangat, P.; Conron, M.; Gabbay, E.; Proudman, S.
2011Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohortNikpour, M.; Hissaria, P.; Byron, J.; Sahhar, J.; Micallef, M.; Paspaliaris, W.; Roddy, J.; Nash, P.; Sturgess, A.; Proudman, S.; Stevens, W.
2018Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestationsThakkar, V.; Patterson, K.; Stevens, W.; Wilson, M.; Roddy, J.; Sahhar, J.; Proudman, S.; Hissaria, P.; Nikpour, M.
2017Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritisWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; Mcwilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.